Initial evaluation of thyroid dysfunction - Are simultaneous TSH and fT4 tests necessary?

Current guidelines suggest a two-step thyroid evaluation, starting with TSH and following with fT4 only if TSH is abnormal. However, many clinicians opt for a one-step approach, testing both hormones simultaneously. Prior research has not fully resolved whether this practice is necessary. Existing studies lack sufficient population diversity or fail to quantify the risk of missing thyroid dysfunction when using a two-step method. It was already known that TSH is a reliable initial marker for thyroid disease. No prior work had resolved the proportion of cases missed by the two-step approach in a general population. This gap motivated researchers to evaluate the two-step strategy in a broad community sample and assess the risk of missing thyroid dysfunction. They also sought to develop a clinical prediction score to guide testing decisions. The study aimed to clarify whether the two-step method is sufficient or if a one-step approach is more appropriate.

The study aimed to compare the two-step and one-step approaches for thyroid dysfunction evaluation in a community-based population. Researchers wanted to determine how often the two-step method misses cases with normal TSH but abnormal fT4. They also aimed to assess whether these missed cases represent true thyroid dysfunction or healthy outliers. The motivation came from uncertainty about the reliability of TSH as a sole initial test. Prior research had shown that TSH is a strong indicator, but questions remained about rare exceptions. The study focused on identifying clinical parameters that could predict thyroid dysfunction risk. By developing a prediction score, the researchers hoped to guide clinicians in deciding when to test fT4. The goal was to determine if the two-step approach is sufficient for most patients.

The study used a cross-sectional design based on data from the Busselton Health Study, a population-based cohort. Researchers compared the two-step and one-step testing approaches by analyzing TSH and fT4 results from 4,471 participants. They focused on cases with normal TSH but out-of-range fT4 to assess the risk of missing thyroid dysfunction. To identify risk factors, they performed likelihood ratio tests on demographic and clinical parameters. A clinical prediction score was developed using beta-coefficient-based scoring. The study evaluated how well the score could identify individuals who might benefit from TSH testing. Researchers also calculated the proportion of participants who would be excluded from TSH testing based on the score. The analysis included statistical comparisons of test results and prediction accuracy.

Using the two-step approach, 93.0% of participants had normal TSH and would not require further testing. The two-step method would have missed 3.8% of participants (169 of 4,471) with normal TSH but abnormal fT4. Of these, 85% (144 of 169) had fT4 values within 2 pmol/l of the reference range, suggesting they were healthy outliers. The clinical prediction score identified only 22.5% of participants as at-risk for thyroid dysfunction. This score excluded the majority of individuals from TSH testing without missing significant cases. The study found that the two-step approach avoids unnecessary fT4 testing in 93% of individuals. The risk of missing true thyroid dysfunction was very low under the two-step method. These findings suggest that simultaneous TSH and fT4 testing may not be necessary for most patients.

The authors propose that the two-step approach is sufficient for most individuals, with a very low risk of missing thyroid dysfunction. They suggest that simultaneous TSH and fT4 testing may not be necessary in routine clinical practice. The study supports the use of TSH as an initial screening test. The clinical prediction score developed in the study may help identify at-risk patients who require further testing. However, the score excludes a large proportion of participants from TSH testing, indicating that most individuals do not need additional testing. The findings suggest that fT4 testing is rarely necessary when TSH is normal. The authors do not propose that the one-step approach is superior to the two-step method. Their results suggest that the two-step approach is practical and avoids unnecessary laboratory costs.